Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.

Scott R. McKercher; Bruce E. Torbett; Kenton L. Anderson; Gregory W. Henkel; Deborah J. Vestal; Hélène Baribault; M Klemsz; Ann J. Feeney; G E Wu; Christopher J. Paige; R. Maki

doi:10.1002/j.1460-2075.1996.tb00949.x

Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.

Scott R. McKercher(Sanford Burnham Prebys Medical Discovery Institute), Bruce E. Torbett(Sanford Burnham Prebys Medical Discovery Institute), Kenton L. Anderson(Sanford Burnham Prebys Medical Discovery Institute), Gregory W. Henkel(Sanford Burnham Prebys Medical Discovery Institute), Deborah J. Vestal(Sanford Burnham Prebys Medical Discovery Institute), Hélène Baribault(Sanford Burnham Prebys Medical Discovery Institute), M Klemsz(Sanford Burnham Prebys Medical Discovery Institute), Ann J. Feeney(Sanford Burnham Prebys Medical Discovery Institute), G E Wu(Sanford Burnham Prebys Medical Discovery Institute), Christopher J. Paige(Sanford Burnham Prebys Medical Discovery Institute), R. Maki(Sanford Burnham Prebys Medical Discovery Institute)

The EMBO Journal

October 1, 1996

10.1002/j.1460-2075.1996.tb00949.x

Cited by 1,123Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis